Literature DB >> 9341784

In vitro responses of human CD45R0brightRA- and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells.

J L Young1, J M Ramage, J S Gaston, P C Beverley.   

Abstract

The cellular basis of immunological memory, particularly with respect to T cells is not understood. In humans, monoclonal antibodies to CD45 have been used to identify memory (CD45R0) and naive (CD45RA) T cells. However, this identification has been called into question by various studies which suggest that high molecular weight CD45 isoforms may be re-expressed by previously activated cells. In the present study, using cultures which supported responses of naive T cells, we examined the responses of purified CD45R0brightRA- or CD45R0(-)-RAbright T cell subsets. The former subset was found to respond preferentially to recall antigens with minimal responses apparent to neo-(or non-recall)-antigens. The inverse pattern was found for CD45R0-RAbright T cells, which converted to CD45R0brightRA- after stimulation with a neo-antigen. Moreover, the two populations of T cells exhibited distinct response kinetics with a faster response evident from the CD45R0brightRA- T cells compared to the CD45R0-RAbright subset. The poor responses of CD45R0-RAbright T cells to recall antigens compared to neo-antigens suggests that this putative naive population is specifically depleted of reactive T cells following an encounter with antigen. We propose that T cell priming results in the stimulation of many CD45R0-RAbright T cells with various T cell receptor specificities from which memory T cells are selected for survival. If re-expression of higher molecular weight isoforms does occur in humans in vivo, our results suggest that R0 expression would be retained (CD45R0+RA+). Alternatively, if primed CD45R0-RAbright T cells exist, they are not prevalent in peripheral blood and thus may be sequestered within lymphoid tissues. Our data support the view that in human peripheral blood, CD45R0bright and CD45RAbright expression identify memory and naive CD4+ T cells, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341784     DOI: 10.1002/eji.1830270937

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen.

Authors:  G Ghaffari; D J Passalacqua; B S Bender; D J Briggs; M M Goodenow; J W Sleasman
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase.

Authors:  C- L Yu; H-S Yu; K-H Sun; S-C Hsieh; C-Y Tsai
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

3.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

4.  CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice.

Authors:  P Andersen; B Smedegaard
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Naive human T cells can be a source of IL-4 during primary immune responses.

Authors:  D M Bullens; K Rafiq; A Kasran; S W Van Gool; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

6.  Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jordan Wulf; Erich D Spaeth; Uzoamaka K Dike; Judith A James; J Donald Capra
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

7.  Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).

Authors:  Vincenzo Formica; Vittore Cereda; Maria-Giovana di Bari; Italia Grenga; Manfredi Tesauro; Palmirotta Raffaele; Patrizia Ferroni; Fiorella Guadagni; Mario Roselli
Journal:  Med Oncol       Date:  2013-10-11       Impact factor: 3.064

8.  Intracellular calcium signalling patterns reflect the differentiation status of human T cells.

Authors:  H P Arrol; L D Church; P A Bacon; S P Young
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

9.  Antigenic experience dictates functional role of glycogen synthase kinase-3 in human CD4+ T cell responses.

Authors:  Carlos A Garcia; Manjunatha R Benakanakere; Pascale Alard; Michelle M Kosiewicz; Denis F Kinane; Michael Martin
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis.

Authors:  Christin Wolfram; Claudia Rasche; Heike Audring; Michael Wahls; Margitta Worm
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.